Back to search
Myelokathexis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Myelokathexis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Myelokathexis trials you may qualify forThis study has a double-blind, Randomized Placebo-Controlled Period and an Open-Label Period. The primary objective of the Randomized Placebo-Controlled Period…
This is a Phase 2 study with an initial 24-week Treatment Period and an Extension Phase. The primary objectives of this Phase 2 study are to determine the safet…